LLY
701.97
+2.52%↑
JNJ
176.85
+1.02%↑
ABBV
206.8
+1%↑
NVS
123.84
+1.28%↑
AZN
79.17
+0.81%↑
LLY
701.97
+2.52%↑
JNJ
176.85
+1.02%↑
ABBV
206.8
+1%↑
NVS
123.84
+1.28%↑
AZN
79.17
+0.81%↑
LLY
701.97
+2.52%↑
JNJ
176.85
+1.02%↑
ABBV
206.8
+1%↑
NVS
123.84
+1.28%↑
AZN
79.17
+0.81%↑
LLY
701.97
+2.52%↑
JNJ
176.85
+1.02%↑
ABBV
206.8
+1%↑
NVS
123.84
+1.28%↑
AZN
79.17
+0.81%↑
LLY
701.97
+2.52%↑
JNJ
176.85
+1.02%↑
ABBV
206.8
+1%↑
NVS
123.84
+1.28%↑
AZN
79.17
+0.81%↑
24h
Praegune
Min
2.09
Max
2.13
Soovitused | Osta |
---|---|
12 kuu keskmine prognoos | +245.75% upside |
Järgmine tulemuste avaldamine | 18. aug 2025 |
---|
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
10. märts 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Loe
10. märts 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Loe
10. märts 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Loe
10. märts 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Loe
10. märts 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Loe
10. märts 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Loe
10. märts 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Loe
Hinnamuutus
By TipRanks
12 kuu keskmine prognoos
Keskmine 7.33 USD 245.75%
Kõrge 16 USD
Madal 2 USD
Põhineb 3 Wall Streeti analüütiku instrumendi Fortress Biotech Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
By TipRanks
Osta
3 ratings
2
Osta
1
Hoia
0
Müü
Põhineb 3 analüütiku instrumendi Fortress Biotech Inc aktsia reitingul - viimase 3 kuu andmed.
$